Half Year 2022 Pro Medicus Ltd Earnings Call Transcript
Thank you for standing by, and welcome to the Pro Medicus PME Half Year Results Briefing. (Operator Instructions) I would now like to hand the conference over to Dr. Sam Hupert, CEO. Please go ahead.
Thanks very much, and good morning. Thanks, everybody, for joining us. For those that are new to us, we're a medical IT company that specializes in enterprise imaging and radiology information systems. We work in 3 jurisdictions: Melbourne, our home office; Berlin, our largest R&D center; and San Diego, the U.S., our largest market. We're very heavily engineering and R&D focused, and the majority or the bulk of our staff work in the engineering and technology part of our business.
In terms of our product set, we have 2 core products: Visage RIS, which was the product we originally developed here in Australia. It does more the commercial side of radiology, the billing, scheduling interface to Medicare and payers; and Visage 7, which is the clinical product, which is
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |